Verges B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care. 2003;26(Suppl 1):S83–6.
PubMed
Google Scholar
American Diabetes Association. 9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S86–s104.
Article
Google Scholar
Soran H, Schofield JD, Adam S, Durrington PN. Diabetic dyslipidaemia. Curr Opin Lipidol. 2016;27(4):313–22.
Article
CAS
PubMed
Google Scholar
Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130–9.
Article
CAS
PubMed
Google Scholar
Staimez LR, Weber MB, Ranjani H, Ali MK, Echouffo-Tcheugui JB, Phillips LS, Mohan V, Narayan KM. Evidence of reduced beta-cell function in Asian Indians with mild dysglycemia. Diabetes Care. 2013;36(9):2772–8.
Article
PubMed
PubMed Central
Google Scholar
Zhou M, Zhu L, Cui X, Feng L, Zhao X, He S, Ping F, Li W, Li Y. The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio as a predictor of insulin resistance but not of beta cell function in a Chinese population with different glucose tolerance status. Lipids Health Dis. 2016;15:104.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chiang JK, Lai NS, Chang JK, Koo M. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovasc Diabetol. 2011;10:93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, Balbin E, Dulbecco CA, Aizpurua M, Marillet AG, Reaven GM. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012;109(12):1749–53.
Article
CAS
PubMed
Google Scholar
Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes. 1995;44(8):863–70.
Article
CAS
PubMed
Google Scholar
Prentki M, Matschinsky FM, Madiraju SR. Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 2013;18(2):162–85.
Article
CAS
PubMed
Google Scholar
Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2008;29(3):351–66.
Article
CAS
PubMed
Google Scholar
Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontes G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta. 2010;1801(3):289–98.
Article
CAS
PubMed
Google Scholar
Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF. Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab. 2011;300(2):E255–62.
Article
CAS
PubMed
Google Scholar
El-Assaad W, Joly E, Barbeau A, Sladek R, Buteau J, Maestre I, Pepin E, Zhao S, Iglesias J, Roche E, et al. Glucolipotoxicity alters lipid partitioning and causes mitochondrial dysfunction, cholesterol, and ceramide deposition and reactive oxygen species production in INS832/13 ss-cells. Endocrinology. 2010;151(7):3061–73.
Article
CAS
PubMed
Google Scholar
Zheng S, Zhou H, Han T, Li Y, Zhang Y, Liu W, Hu Y. Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride. BMC Endocr Disord. 2015;15:21.
Article
PubMed
PubMed Central
CAS
Google Scholar
Natali A, Baldi S, Bonnet F, Petrie J, Trifiro S, Trico D, Mari A. Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects. Metabolism. 2017;69:33–42.
Article
CAS
PubMed
Google Scholar
Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia. 2002;45(1):85–96.
Article
CAS
PubMed
Google Scholar
Karunakaran U, Park KG. A systematic review of oxidative stress and safety of antioxidants in diabetes: focus on islets and their defense. Diabetes Metab J. 2013;37(2):106–12.
Article
PubMed
PubMed Central
Google Scholar
Robertson R, Zhou H, Zhang T, Harmon JS. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys. 2007;48(2–3):139–46.
Article
CAS
PubMed
Google Scholar
Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci. 2004;1011:168–76.
Article
CAS
PubMed
Google Scholar
Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI Jr, Newsholme P. Molecular Events Linking Oxidative Stress and Inflammation to Insulin Resistance and beta-Cell Dysfunction. Oxid Med Cell Longev. 2015;2015:181643. https://doi.org/10.1155/2015/181643.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang J, Wang H. Oxidative Stress in Pancreatic Beta Cell Regeneration. Oxid Med Cell Longev. 2017;2017:1930261. https://doi.org/10.1155/2017/1930261.
Article
CAS
PubMed
PubMed Central
Google Scholar
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.
Article
Google Scholar
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
Article
CAS
PubMed
Google Scholar
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–70.
Article
CAS
PubMed
Google Scholar
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10.
Article
CAS
PubMed
Google Scholar
Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes. 1995;44(12):1386–91.
Article
CAS
PubMed
Google Scholar
Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis. 2010;20(2):79–86.
Article
CAS
PubMed
Google Scholar
Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care. 2007;30(6):1544–8. https://doi.org/10.2337/dc06-1331.
Article
PubMed
Google Scholar
Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, et al. Prevalence and control of diabetes in Chinese adults. Jama. 2013;310(9):948–59.
Article
CAS
PubMed
Google Scholar
Opoku S, Gan Y, Fu W, Chen D, Addo-Yobo E, Trofimovitch D, Yue W, Yan F, Wang Z, Lu Z. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC Public Health. 2019;19(1):1500.
Article
PubMed
PubMed Central
CAS
Google Scholar
Liu X, Yu S, Mao Z, Li Y, Zhang H, Yang K, Zhang H, Liu R, Qian X, Li L, et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis. 2018;17(1):119.
Article
PubMed
PubMed Central
Google Scholar
Zhang FL, Xing YQ, Wu YH, Liu HY, Luo Y, Sun MS, Guo ZN, Yang Y. The prevalence, awareness, treatment, and control of dyslipidemia in Northeast China: a population-based cross-sectional survey. Lipids Health Dis. 2017;16(1):61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zheng S, Xu H, Zhou H, Ren X, Han T, Chen Y, Qiu H, Wu P, Zheng J, Wang L, et al. Associations of lipid profiles with insulin resistance and beta cell function in adults with normal glucose tolerance and different categories of impaired glucose regulation. PLoS One. 2017;12(2):e0172221. https://doi.org/10.1371/journal.pone.0172221.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koh KK, Oh PC, Sakuma I, Lee Y, Han SH, Shin EK. Vascular and metabolic effects of omega-3 fatty acids combined with fenofibrate in patients with hypertriglyceridemia. Int J Cardiol. 2016;221:342–6.
Article
PubMed
Google Scholar
Zhou M, Li Z, Min R, Dong Y, Sun Q, Li Y. Log (TG)/HDL-C ratio as a predictor of decreased islet beta cell function in patients with type 2 diabetes: 6-year cohort study. J Diabetes. 2015;7(5):689–98.
Article
PubMed
Google Scholar
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF. And endocrine s. evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, Palmiero P, Saba PS, Pedrinelli R, Ciccone MM. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11–32.
Article
CAS
Google Scholar
Rastogi A, Dunbar RL, Thacker HP, Bhatt J, Parmar K, Parmar DV. Abrogation of postprandial triglyceridemia with dual PPAR alpha/gamma agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study. Acta Diabetol. 2020. https://doi.org/10.1007/s00592-020-01487-8.
Jain N, Bhansali S, Kurpad AV, Hawkins M, Sharma A, Kaur S, Rastogi A, Bhansali A. Effect of a dual PPAR alpha/gamma agonist on insulin sensitivity in patients of type 2 diabetes with hypertriglyceridemia- randomized double-blind placebo-controlled trial. Sci Rep. 2019;9(1):19017. https://doi.org/10.1038/s41598-019-55466-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Colak E, Majkic-Singh N, Stankovic S, Sreckovic-Dimitrijevic V, Djordjevic PB, Lalic K, Lalic N. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications. Ann Med. 2005;37(8):613–20.
Article
CAS
PubMed
Google Scholar
Wong FN, Chua KH, Tan J, Wong CM, Kuppusamy UR. Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE. PeerJ. 2018;6:e4421. https://doi.org/10.7717/peerj.4421.
Article
CAS
PubMed
PubMed Central
Google Scholar
Picu A, Petcu L, Stefan S, Mitu M, Lixandru D, Ionescu-Tirgoviste C, Pircalabioru GG, Ciulu-Costinescu F, Bubulica MV, Chifiriuc MC. Markers of Oxidative Stress and Antioxidant Defense in Romanian Patients with Type 2 Diabetes Mellitus and Obesity. Molecules. 2017;22(5). https://doi.org/10.3390/molecules22050714.
Aouacheri O, Saka S, Krim M, Messaadia A, Maidi I. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can J Diabetes. 2015;39(1):44–9.
Article
PubMed
Google Scholar
Isogawa A, Yamakado M, Yano M, Shiba T. Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness. Diabetes Res Clin Pract. 2009;86(3):213–8.
Article
CAS
PubMed
Google Scholar
Perriotte-Olson C, Adi N, Manickam DS, Westwood RA, Desouza CV, Natarajan G, Crook A, Kabanov AV, Saraswathi V. Nanoformulated copper/zinc superoxide dismutase reduces adipose inflammation in obesity. Obesity (Silver Spring). 2016;24(1):148–56.
Article
CAS
Google Scholar
Natarajan G, Perriotte-Olson C, Bhinderwala F, Powers R, Desouza CV, Talmon GA, Yuhang J, Zimmerman MC, Kabanov AV, Saraswathi V. Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling. Transl Res. 2017;188:10–26.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U S A. 1989;86(24):9697–701.
Article
CAS
PubMed
PubMed Central
Google Scholar
Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2′ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2009;27(2):120–39.
Article
CAS
PubMed
Google Scholar
Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339(1–2):1–9.
Article
CAS
PubMed
Google Scholar
Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia. 1999;42(8):995–8.
Article
CAS
PubMed
Google Scholar
Al-Aubaidy HA, Jelinek HF. 8-Hydroxy-2-deoxy-guanosine identifies oxidative DNA damage in a rural prediabetes cohort. Redox Rep. 2010;15(4):155–60.
Article
CAS
PubMed
Google Scholar
Al-Aubaidy HA, Jelinek HF. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur J Endocrinol. 2011;164(6):899–904.
Article
CAS
PubMed
Google Scholar